These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22492951)

  • 1. Rivaroxaban to prevent pulmonary embolism after hip or knee replacement.
    Cios D; Fanikos J
    Circulation; 2012 Apr; 125(14):e542-4. PubMed ID: 22492951
    [No Abstract]   [Full Text] [Related]  

  • 2. Rivaroxaban for thromboprophylaxis after hip or knee replacement surgery.
    Belavic JM
    Nurse Pract; 2012 May; 37(5):6-8. PubMed ID: 22543875
    [No Abstract]   [Full Text] [Related]  

  • 3. Rivaroxaban for thromboprophylaxis.
    Lotke PA
    N Engl J Med; 2008 Nov; 359(20):2174; author reply 2175-6. PubMed ID: 19009675
    [No Abstract]   [Full Text] [Related]  

  • 4. Rivaroxaban (Xarelto)--a new oral anticoagulant.
    Med Lett Drugs Ther; 2011 Aug; 53(1371):65-7. PubMed ID: 21860366
    [No Abstract]   [Full Text] [Related]  

  • 5. An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
    Lereun C; Wells P; Diamantopoulos A; Rasul F; Lees M; Sengupta N
    J Med Econ; 2011; 14(2):238-44. PubMed ID: 21385145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.
    Alves C; Batel-Marques F; Macedo AF
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):266-76. PubMed ID: 22134134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
    Kwong LM
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism after total hip arthroplasty and total knee arthroplasty: current and future perspectives. Epilogue.
    Merli G
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S33. PubMed ID: 21548181
    [No Abstract]   [Full Text] [Related]  

  • 9. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
    Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
    N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.
    Friedman RJ; Sengupta N; Lees M
    Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):299-306. PubMed ID: 21671699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylaxis of thrombembolic diseases with rivaroxaban].
    Gassanov N; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2189-92. PubMed ID: 20979005
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme.
    Lassen MR; Gent M; Kakkar AK; Eriksson BI; Homering M; Berkowitz SD; Turpie AG
    J Bone Joint Surg Br; 2012 Nov; 94(11):1573-8. PubMed ID: 23109641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivaroxaban: new drug. After hip or knee replacement surgery: LMWH is safer.
    Prescrire Int; 2009 Aug; 18(102):151-3. PubMed ID: 19743567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism after total hip arthroplasty and total knee arthroplasty: current and future perspectives.
    Merli G
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S4-5. PubMed ID: 21548183
    [No Abstract]   [Full Text] [Related]  

  • 15. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
    Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W;
    N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of rivaroxaban for chemical thromboprophylaxis following total knee replacement.
    Rath NK; Goodson MW; White SP; Forster MC
    Knee; 2013 Dec; 20(6):397-400. PubMed ID: 23566737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.
    Clayton RA; Gaston P; Howie CR
    J Bone Joint Surg Br; 2010 Mar; 92(3):468; author reply 468. PubMed ID: 20217988
    [No Abstract]   [Full Text] [Related]  

  • 18. Rivaroxaban: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
    Duggan ST; Scott LJ; Plosker GL
    Drugs; 2009; 69(13):1829-51. PubMed ID: 19719335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions with rivaroxaban following total joint replacement surgery.
    Kwong LM; Tong LM
    Ann Pharmacother; 2012 Sep; 46(9):1232-8. PubMed ID: 22932305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
    Eriksson BI; Rosencher N; Friedman RJ; Homering M; Dahl OE
    Thromb Res; 2012 Aug; 130(2):147-51. PubMed ID: 22225858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.